Endocrinopathies: Chronic Thyroiditis, Addison Disease, Pernicious Anemia, Graves’ Disease, Diabetes, and Hypophysitis

Chronic lymphocytic thyroiditis (CLT), also known as Hashimoto thyroiditis, is an autoimmune disease characterized by lymphocytic infiltration of the thyroid gland, with the concomitant production of autoantibodies to thyroid antigens, primarily thyroglobulin and/or thyroperoxidase (TPO), formerly known as microsomal antigen (1). Although few epidemiological data are available, the prevalence of CLT is estimated to be 1 in 1,000 people, with an incidence of 0.2 to 2% and a female-to-male ratio of about 18:1 (1). Clinical signs and symptoms manifest slowly and may involve many systems of the body (1). Accumulations of hydrophilic mucoproteins with edema, a condition called myxedema, affects skin and connective tissue and can affect the appearance of the individual. Lethargy may ensue, with a loss of mental acuity. Systems commonly affected are the gastrointestinal tract, the hemopoietic system, the endocrine system, and the urogenital system (1). Enlargement of the thyroid gland due to lymphocyte invasion, called goiter, is a frequent manifestation, although there is an atrophic variation. Demonstration of autoantibodies to the thyroid antigens aids in the diagnosis of CLT, distinguishing it from other causes of hypothyroidism.

[1]  M. Rewers,et al.  GAD65 Autoantibodies Detected by Electrochemiluminescence Assay Identify High Risk for Type 1 Diabetes , 2013, Diabetes.

[2]  P. Caturegli,et al.  From Japan with love: another tessera in the hypophysitis mosaic. , 2013, The Journal of clinical endocrinology and metabolism.

[3]  S. Radovick,et al.  Isolated prolactin deficiency associated with serum autoantibodies against prolactin-secreting cells. , 2013, The Journal of clinical endocrinology and metabolism.

[4]  E. Bonifacio,et al.  Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. , 2013, JAMA.

[5]  G. Barbesino,et al.  Clinical Utility of TSH Receptor Antibodies , 2013 .

[6]  A. Steck,et al.  Proinsulin/Insulin Autoantibodies Measured With Electrochemiluminescent Assay Are the Earliest Indicator of Prediabetic Islet Autoimmunity , 2013, Diabetes Care.

[7]  B. Rapoport,et al.  Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa. , 2013, Thyroid : official journal of the American Thyroid Association.

[8]  D. Giavarina,et al.  TSH receptor autoantibody immunoassay in patients with Graves' disease: improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis. , 2012, Autoimmunity reviews.

[9]  M. Rewers,et al.  Distinguishing Persistent Insulin Autoantibodies With Differential Risk , 2011, Diabetes.

[10]  P. D. Olivo,et al.  Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease. , 2011, Thyroid : official journal of the American Thyroid Association.

[11]  R. Negro,et al.  2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. , 2011, Thyroid : official journal of the American Thyroid Association.

[12]  M. Tiemann,et al.  Non-specific binding of antibodies in immunohistochemistry: fallacies and facts , 2011, Scientific reports.

[13]  S. Hutfless,et al.  Significance of prediagnostic thyroid antibodies in women with autoimmune thyroid disease. , 2011, The Journal of clinical endocrinology and metabolism.

[14]  M. Rewers,et al.  Age of Islet Autoantibody Appearance and Mean Levels of Insulin, but Not GAD or IA-2 Autoantibodies, Predict Age of Diagnosis of Type 1 Diabetes , 2011, Diabetes Care.

[15]  R. Núñez Miguel,et al.  Crystal structure of the TSH receptor (TSHR) bound to a blocking-type TSHR autoantibody. , 2011, Journal of molecular endocrinology.

[16]  L. Rönnblom,et al.  TSGA10 – A Target for Autoantibodies in Autoimmune Polyendocrine Syndrome Type 1 and Systemic Lupus Erythematosus , 2011, Scandinavian journal of immunology.

[17]  P. O S I T I O N S T A T E M E N T,et al.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[18]  M. Rotondi,et al.  Predictive role of the immunostaining pattern of immunofluorescence and the titers of antipituitary antibodies at presentation for the occurrence of autoimmune hypopituitarism in patients with autoimmune polyendocrine syndromes over a five-year follow-up. , 2010, The Journal of clinical endocrinology and metabolism.

[19]  P. Bingley,et al.  Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for national institute of diabetes and digestive and kidney diseases consortia. , 2010, The Journal of clinical endocrinology and metabolism.

[20]  T. Tagami,et al.  ORIGINAL ARTICLE: Monoclonal autoantibodies to the TSH receptor, one with stimulating activity and one with blocking activity, obtained from the same blood sample , 2010, Clinical endocrinology.

[21]  Shey-Cherng Tzou,et al.  Autoimmune hypophysitis: expanding the differential diagnosis to CTLA-4 blockade , 2009, Expert review of endocrinology & metabolism.

[22]  V. Rohde,et al.  A Radiologic Score to Distinguish Autoimmune Hypophysitis from Nonsecreting Pituitary Adenoma Preoperatively , 2009, American Journal of Neuroradiology.

[23]  H. Siljander,et al.  Predictive Characteristics of Diabetes-Associated Autoantibodies Among Children With HLA-Conferred Disease Susceptibility in the General Population , 2009, Diabetes.

[24]  Jeffrey P. Krischer,et al.  Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1 , 2009, Diabetes Care.

[25]  C. Massart,et al.  Clinical value of M22-based assays for TSH-receptor antibody (TRAb) in the follow-up of antithyroid drug treated Graves' disease: comparison with the second generation human TRAb assay. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[26]  H. Chase,et al.  Diabetic Subjects Diagnosed Through the Diabetes Prevention Trial–Type 1 (DPT-1) Are Often Asymptomatic With Normal A1C at Diabetes Onset , 2009, Diabetes Care.

[27]  G. Eisenbarth,et al.  Murine high specificity/sensitivity competitive europium insulin autoantibody assay. , 2009, Diabetes technology & therapeutics.

[28]  G. Eisenbarth,et al.  A Common Nonsynonymous Single Nucleotide Polymorphism in the SLC30A8 Gene Determines ZnT8 Autoantibody Specificity in Type 1 Diabetes , 2008, Diabetes.

[29]  G. Eisenbarth,et al.  Accepting clocks that tell time poorly: fluid-phase versus standard ELISA autoantibody assays. , 2007, Clinical immunology.

[30]  Marian Rewers,et al.  The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes , 2007, Proceedings of the National Academy of Sciences.

[31]  K. Kamijo TSH-receptor antibodies determined by the first, second and third generation assays and thyroid-stimulating antibody in pregnant patients with Graves' disease. , 2007, Endocrine journal.

[32]  T. Blundell,et al.  Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody. , 2007, Thyroid : official journal of the American Thyroid Association.

[33]  P. Caturegli Autoimmune hypophysitis: an underestimated disease in search of its autoantigen(s). , 2007, The Journal of clinical endocrinology and metabolism.

[34]  田攀文,et al.  Autoimmune hypophysitis , 2007 .

[35]  T. Hudson,et al.  A genome-wide association study identifies novel risk loci for type 2 diabetes , 2007, Nature.

[36]  T. Hökfelt,et al.  Pituitary autoantibodies in autoimmune polyendocrine syndrome type 1 , 2007, Proceedings of the National Academy of Sciences.

[37]  C. Carella,et al.  Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period. , 2006, Thyroid : official journal of the American Thyroid Association.

[38]  P. Bingley,et al.  Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk , 2006, Diabetologia.

[39]  Megumi Tanaka,et al.  Clinical evaluation of 3rd generation assay for thyrotropin receptor antibodies: the M22-biotin-based ELISA initiated by Smith. , 2005, Endocrine journal.

[40]  C. Betterle,et al.  Adrenal cortex autoantibodies in subjects with normal adrenal function. , 2005, Best practice & research. Clinical endocrinology & metabolism.

[41]  K. Takano,et al.  Rapid differential diagnosis of Graves' disease and painless thyroiditis using total T3/T4 ratio, TSH, and total alkaline phosphatase activity. , 2005, Endocrine journal.

[42]  D. Weightman,et al.  A new assay for thyrotropin receptor autoantibodies. , 2004, Thyroid : official journal of the American Thyroid Association.

[43]  B. Rapoport,et al.  Affinity-enrichment of thyrotropin receptor autoantibodies from Graves' patients and normal individuals provides insight into their properties and possible origin from natural antibodies. , 2004, The Journal of clinical endocrinology and metabolism.

[44]  T. Blundell,et al.  Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function. , 2004, Thyroid : official journal of the American Thyroid Association.

[45]  E. Bonifacio,et al.  Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes. , 2004, The Journal of clinical investigation.

[46]  M. Rewers,et al.  Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young (DAISY). , 2004, The Journal of clinical endocrinology and metabolism.

[47]  M. Rewers,et al.  Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. , 2004, Diabetes care.

[48]  B. Rapoport,et al.  Thyroid stimulation does not require antibodies with identical epitopes but does involve recognition of a critical conformation at the N terminus of the thyrotropin receptor A-subunit. , 2004, The Journal of clinical endocrinology and metabolism.

[49]  P. Bingley,et al.  Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. , 2004, Diabetes.

[50]  T. Takano,et al.  Frequent appearance of autoantibodies against prohormone convertase 1/3 and neuroendocrine protein 7B2 in patients with nonfunctioning pituitary macroadenoma , 2003, Endocrine.

[51]  C. Betterle,et al.  A sensitive non-isotopic assay for GAD65 autoantibodies. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[52]  T. Takano,et al.  Detection of autoantibodies against the pituitary-specific proteins in patients with lymphocytic hypophysitis. , 2002, European journal of endocrinology.

[53]  P. Crock,et al.  Identification of the 49-kDa Autoantigen Associated with Lymphocytic Hypophysitis as α-Enolase , 2002 .

[54]  T. Takao,et al.  Antipituitary Antibodies in Patients with Lymphocytic Hypophysitis , 2002, Hormone Research in Paediatrics.

[55]  James W. Thomas,et al.  Anergy and not Clonal Ignorance Determines the Fate of B Cells that Recognize a Physiological Autoantigen1 , 2001, The Journal of Immunology.

[56]  M. Rewers,et al.  Humoral autoreactivity to an alternatively spliced variant of ICA512/IA-2 in Type I diabetes , 2000, Diabetologia.

[57]  M. Rewers,et al.  Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[58]  C. Chapman,et al.  Measurement of thyroid-stimulating hormone receptor autoantibodies by ELISA. , 1999, Clinical chemistry.

[59]  M. Polak,et al.  Sera from Children with Type 1 Diabetes mellitus React against a New Group of Antigens Composed of Lysophospholipids , 1999, Hormone Research in Paediatrics.

[60]  E. Bonifacio,et al.  Early autoantibody responses in prediabetes are IgG1 dominated and suggest antigen-specific regulation. , 1999, Journal of immunology.

[61]  W. Staines,et al.  Reduction of Lipofuscin-like Autofluorescence in Fluorescently Labeled Tissue , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[62]  E. Bonifacio,et al.  Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. , 1999, Diabetes.

[63]  O. Pinhas-Hamiel,et al.  Type 2 diabetes in adolescents, no longer rare. , 1998, Pediatrics in review.

[64]  Watson,et al.  A new chemiluminescent assay for the rapid detection of thyroid stimulating antibodies in Graves' disease , 1998, Clinical endocrinology.

[65]  L. Harrison,et al.  IgG subclass antibodies to glutamic acid decarboxylase and risk for progression to clinical insulin-dependent diabetes. , 1998, Human immunology.

[66]  T. Kanda,et al.  Determination of antipituitary antibody in patients with endocrine disorders by enzyme-linked immunosorbent assay and Western blot analysis. , 1998, The Journal of laboratory and clinical medicine.

[67]  J. Lazarus Prediction of postpartum thyroiditis. , 1998, European journal of endocrinology.

[68]  T. Kobayashi,et al.  Studies on circulating anti-pituitary antibodies in NIDDM patients. , 1998, Endocrine journal.

[69]  H. Chase,et al.  Dual-parameter model for prediction of type I diabetes mellitus. , 1998, Proceedings of the Association of American Physicians.

[70]  W. Scherbaum,et al.  Application of a Bioassay with CHO Cells for the Routine Detection of Stimulating and Blocking Autoantibodies to the TSH-Receptor , 1998, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[71]  R. Holman,et al.  UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes , 1997, The Lancet.

[72]  P. Bingley,et al.  A novel micro-assay for insulin autoantibodies. , 1997, Journal of autoimmunity.

[73]  S J Gange,et al.  Epidemiology and estimated population burden of selected autoimmune diseases in the United States. , 1997, Clinical immunology and immunopathology.

[74]  M. Lan,et al.  IA-2 and IA-2 beta are major autoantigens in IDDM and the precursors of the 40 kDa and 37 kDa tryptic fragments. , 1996, Journal of autoimmunity.

[75]  M. Atkinson,et al.  Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition. , 1996, Journal of immunology.

[76]  Roberto Gianani,et al.  ICA512 Autoantibody Radioassay , 1995, Diabetes.

[77]  S. Ishii,et al.  Western blot analysis of rat pituitary antigens recognized by human antipituitary antibodies. , 1995, Endocrine journal.

[78]  D. Goldstein,et al.  Islet cell antigen 512 is a diabetes-specific islet autoantigen related to protein tyrosine phosphatases. , 1994, Journal of immunology.

[79]  A. Ziegler,et al.  Characterization of Insulin Autoantibodies in Relatives of Patients With Type I Diabetes , 1993, Diabetes.

[80]  K. Tokunaga,et al.  Patients with Graves' disease who developed insulin autoimmune syndrome (Hirata disease) possess HLA-Bw62/Cw4/DR4 carrying DRB1*0406. , 1993, The Journal of clinical endocrinology and metabolism.

[81]  P. Crock,et al.  Detection of anti-pituitary autoantibodies by immunoblotting. , 1993, Journal of immunological methods.

[82]  Å. Lernmark,et al.  Autoantibodies in IDDM Primarily Recognize the 65,000-Mr Rather Than 67,000-Mr Isoform of Glutamic Acid Decarboxylase , 1993, Diabetes.

[83]  A. Pinchera,et al.  Detection of thyroid-stimulating antibody using Chinese hamster ovary cells transfected with cloned human thyrotropin receptor. , 1993, The Journal of clinical endocrinology and metabolism.

[84]  M. Parmentier,et al.  Stable expression of the human TSH receptor in CHO cells and characterization of differentially expressing clones. , 1990, Biochemical and biophysical research communications.

[85]  S. Baekkeskov,et al.  Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase , 1990, Nature.

[86]  R. Williams,et al.  Thyroid-stimulating antibody activity between different immunoglobulin G subclasses. , 1990, The Journal of clinical investigation.

[87]  S. Nagataki,et al.  Development of spontaneous hypothyroidism in patients with Graves' disease treated with antithyroidal drugs: clinical, immunological, and histological findings in 26 patients. , 1989, The Journal of clinical endocrinology and metabolism.

[88]  G. Eisenbarth,et al.  Binding of Cytoplasmic Islet Cell Antibodies Is Blocked by Human Pancreatic Glycolipid Extracts , 1988, Diabetes.

[89]  A. Pinchera,et al.  Measurement of TSAb directly in serum using FRTL-5 cells , 1988, Journal of endocrinological investigation.

[90]  J. Konishi,et al.  A sensitive and practical assay for thyroid-stimulating antibodies using FRTL-5 thyroid cells. , 1987, Acta endocrinologica.

[91]  J. Konishi,et al.  A sensitive and practical assay for thyroid-stimulating antibodies using crude immunoglobulin fractions precipitated with polyethylene glycol. , 1986, The Journal of clinical endocrinology and metabolism.

[92]  B. Czarnocka,et al.  Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases , 1985, FEBS letters.

[93]  V. Rohmer,et al.  CIRCULATING PITUITARY AUTOANTIBODIES AGAINST CELLS SECRETING LUTEINISING AND FOLLICLE STIMULATING HORMONES IN CHILDREN WITH CRYPTORCHIDISM , 1984, The Lancet.

[94]  B. Smith,et al.  A RECEPTOR ASSAY FOR THE MEASUREMENT OF TSH RECEPTOR ANTIBODIES IN UNEXTRACTED SERUM , 1984, Clinical endocrinology.

[95]  J. Palmer,et al.  Insulin antibodies in insulin-dependent diabetics before insulin treatment. , 1983, Science.

[96]  S. Filetti,et al.  Thyroid-stimulating immunoglobulin bioassay using cultured human thyroid cells. , 1981, The Journal of clinical endocrinology and metabolism.

[97]  C. Rotella,et al.  Thyroid-stimulating antibody (TSab) detected in sera of Graves' patients using human thyroid cell cultures. , 1980, Clinical and experimental immunology.

[98]  J. Konishi,et al.  Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis. , 1978, The Journal of clinical endocrinology and metabolism.

[99]  D. Doniach,et al.  Binding of human immunoglobulins to pituitary ACTH cells , 1976, Nature.

[100]  D. Doniach,et al.  AUTOANTIBODIES TO PROLACTIN-SECRETING CELLS OF HUMAN PITUITARY , 1975, The Lancet.

[101]  N. Maclaren,et al.  ANTIBODY TO CULTURED HUMAN INSULINOMA CELLS IN INSULIN-DEPENDENT DIABETES , 1975, The Lancet.

[102]  D. R. Gamble,et al.  ISLET-CELL ANTIBODIES IN JUVENILE DIABETES MELLITUS OF RECENT ONSET , 1975, The Lancet.

[103]  D. Doniach,et al.  Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. , 1974, Lancet.

[104]  B. Smith,et al.  THYROID-STIMULATING IMMUNOGLOBULINS IN GRAVES' DISEASE , 1974 .

[105]  L. J. Roth,et al.  Thin Sections cut at Temperatures of −70° to −90° C , 1965, Nature.

[106]  O. Engelberth,et al.  [Autoantibodies in Sheehan's syndrome]. , 1965, Vnitrni lekarstvi.

[107]  R. B. Goudie,et al.  Anterior hypophysitis and Hashimoto's disease in a young woman. , 1962, The Journal of pathology and bacteriology.

[108]  J. Mckenzie The bioassay of thyrotropin in serum. , 1958, Endocrinology.

[109]  P. Gleeson,et al.  Autoimmune Gastritis and Pernicious Anemia , 2014 .

[110]  C. Betterle,et al.  Chapter 42 – Adrenalitis , 2014 .

[111]  Jozélio Freire de Carvalho,et al.  Autoimmune Addison Disease or Autoimmune Adrenalitis , 2008 .

[112]  M. Rewers,et al.  Prevalence of autoantibody-negative diabetes is not rare at all ages and increases with older age and obesity. , 2007, The Journal of clinical endocrinology and metabolism.

[113]  G. Eisenbarth,et al.  Type 1 diabetes mellitus of man: genetic susceptibility and resistance. , 2004, Advances in experimental medicine and biology.

[114]  K. Usadel,et al.  Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. , 1999, The Journal of clinical endocrinology and metabolism.

[115]  A. Weetman Autoimmunity to steroid-producing cells and familial polyendocrine autoimmunity. , 1995, Bailliere's clinical endocrinology and metabolism.

[116]  N. Rose,et al.  Autoantigenic determinants on human thyroglobulin. II. Determinants recognized by autoantibodies from patients with chronic autoimmune thyroiditis compared to autoantibodies from healthy subjects. , 1990, Clinical immunology and immunopathology.

[117]  J. Konishi,et al.  A new in vitro assay for human thyroid stimulator using cultured thyroid cells: effect of sodium chloride on adenosine 3',5'-monophosphate increase. , 1982, The Journal of clinical endocrinology and metabolism.